Literature DB >> 26482550

In vitro susceptibility of contagious ovine digital dermatitis associated Treponema spp. isolates to antimicrobial agents in the UK.

Joseph W Angell1, Simon R Clegg2, Leigh E Sullivan2, Jennifer S Duncan1, Dai H Grove-White1, Stuart D Carter2, Nicholas J Evans2.   

Abstract

BACKGROUND: Contagious ovine digital dermatitis (CODD) is an important cause of infectious lameness in sheep in the UK and Ireland and has a severe impact on the welfare of affected individuals. The three treponemal phylogroups Treponema medium/Treponema vincentii-like, Treponema phagedenis-like and Treponema pedis spirochaetes have been associated with clinical CODD lesions and are considered to be a necessary cause of disease. There are scant data on the antimicrobial susceptibility of the treponemes cultured from CODD lesions.
OBJECTIVE: The aim of this study was to determine in vitro the miniumum inhibitory concentration/ minimum bactericidal concentration (MIC/MBC) of antimicrobials used in the sheep industry for isolates of the three CODD associated treponeme phylogroups T. medium/T. vincentii-like, T. phagedenis-like and T. pedis. ANIMALS: Twenty treponeme isolates; from 19 sheep with clinical CODD lesions.
METHODS: A microdilution method was used to determine in vitro the MIC/MBC of 10 antimicrobial agents for 20 treponeme isolates (five T. medium/T. vincentii-like, 10 T. phagedenis-like and five T. pedis). The antimicrobials tested were penicillin G, amoxicillin, oxytetracycline, tilmicosin, lincomycin, spectinomycin, tylosin, tildipirosin, tulathromycin and gamithromycin.
RESULTS: The treponeme isolates tested showed low MICs and MBCs to all 10 antimicrobials tested. They were most susceptible to gamithromycin and tildipirosin (MIC90: 0.0469 mg/L), and were least susceptible to lincomycin, spectinomycin and oxytetracycline (MIC90: 48 mg/L, 24 mg/L and 3 mg/L, respectively).
CONCLUSIONS: These data are comparable to in vitro antimicrobial susceptibility data for treponemes cultured from bovine digital dermatitis lesions. Dependent on local licensing, penicillin and tilmicosin appear to be the best candidates for future in vivo studies.
© 2015 The Authors. Veterinary Dermatology published by John Wiley & Sons Ltd on behalf of the ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26482550      PMCID: PMC4982079          DOI: 10.1111/vde.12269

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


Introduction

Contagious ovine digital dermatitis (CODD) is a cause of infectious lameness in sheep in the UK and Ireland and has been shown to have a severe impact on the welfare of affected individuals.1 Recent surveys have shown that CODD may affect approximately 35% of flocks in the UK; while on‐farm prevalence is typically low, it may affect up to 50% of the flock at any one time.1 Information about the microbial flora of CODD lesions is limited, although the bovine digital dermatitis (BDD) associated treponemes Treponema medium/T. vincentii‐like, Treponema phagedenis‐like and Treponema pedis are currently considered to be a necessary cause of disease.1 The recent characterization of treponemes associated with CODD demonstrated the presence of at least one BDD phylotype present in all 58 lesions studied, whereas these were totally absent from all healthy sheep foot tissues.2 There has been a wide range of empirically chosen treatments employed in clinical cases such as parenteral oxytetracycline and topical tylosin,3 with only one randomized controlled trial conducted comparing parenteral amoxicillin and simultaneous topical chlortetracycline with topical chlortetracycline alone.4 As with CODD, the successful treatment of BDD has remained problematic with many farms adopting management and control strategies as opposed to affecting a cure.5 In order to inform the development of effective therapeutic strategies for clinical cases of CODD, a greater understanding is required of the susceptibility of the treponemes found in CODD lesions to antimicrobials currently available for use in sheep. The aim of this study was to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of a panel of antimicrobials for representatives from each of the three treponeme phylogroups cultured as pure isolates from clinical CODD lesions.

Materials and methods

Bacterial isolates

Twenty treponeme isolates from CODD lesions from 19 sheep from six farms in England, Wales and Northern Ireland were used (Table 1). Included were five isolates from the T. medium/T. vincentii‐like group, 10 isolates from the T. phagedenis‐like group and five isolates from the T. pedis group.
Table 1

Treponemes tested for susceptibility to antimicrobial agents

Strain no.StrainIsolation dateUK LocationNearest related organisma
1G1F7C507/2013Conwy Treponema medium/Treponema vincentii
2G1F9C2707/2013Conwy Treponema medium/Treponema vincentii
3G1OV1108/2009Gloucester Treponema medium/Treponema vincentii
4G2S2R02/2009Cheshire Treponema medium/Treponema vincentii
5ST2707/2013Conwy Treponema medium/Treponema vincentii
63F202/2014Anglesey Treponema phagedenis
7C2F06/2009Gloucestershire Treponema phagedenis
8G2S4F02/2009Cheshire Treponema phagedenis
9G2F3C1207/2013Conwy Treponema phagedenis
10G13F302/2014Denbighshire Treponema phagedenis
11G2SL105/2014Anglesey Treponema phagedenis
12G23F102/2014Anglesey Treponema phagedenis
13S3R203/2009Cheshire Treponema phagedenis
14G2ST2407/2013Conwy Treponema phagedenis
15C2R06/2009Gloucestershire Treponema phagedenis
16Ovine (G179)2000Northern Ireland Treponema pedis
17G3ST107/2014Shrewsbury Treponema pedis
18G3S4507/2014Shrewsbury Treponema pedis
19G3T107/2014Shrewsbury Treponema pedis
20G3T707/2014Shrewsbury Treponema pedis

As determined by 16S rRNA gene phylogenetic analysis.

Treponemes tested for susceptibility to antimicrobial agents As determined by 16S rRNA gene phylogenetic analysis.

In vitro antimicrobial susceptibility testing

The MIC/MBC for each antimicrobial was determined using a broth microdilution method as previously described.6 One small adjustment was made to the method such that prior to inoculation, bacterial counts were assessed by determining the optical density (OD) of the cultures using spectrometry with wavelength set at 540 nm. The T. medium/T. vincentii‐like cultures had an OD of 0.25; the T. phagedenis‐like cultures had an OD of 0.43 and the T. pedis cultures had an OD of 0.37. This corresponds to 8.75 × 107, 1.14 × 108 and 2.69 × 108 treponemal organisms/mL, respectively.6 At this time point, cultures were assessed by phase contrast microscopy to determine that the cultures were alive, of the correct morphology and lacking contaminants. The antimicrobials and their test ranges are listed in Table 2.
Table 2

Minimum inhibitory concentrations (MIC) of 10 antimicrobial agents tested against contagious ovine digital dermatitis associated treponemes

Strain no.a Median MIC (mg/L)
PenicillinAmoxicillinOxytetracyclineTilmicosinLincomycinSpectinomycinTildipirosinTulathromycinGamithromycinTylosin
10.07500.562530.070324120.02340.29300.04690.0469
20.03750.281330.023448240.02340.29300.02340.0234
30.03750.56251.50.011748120.04691.17190.04690.0234
40.07500.28131.50.023424120.04690.29300.02340.0469
50.07500.562530.011724240.04691.17190.04690.0469
60.03750.14060.750.023424120.04690.58590.04690.0469
70.01880.14060.750.046912120.09380.58590.01170.0469
80.07500.28130.3750.009412120.04690.29300.01170.0469
90.03750.14060.750.187524120.04690.58590.02340.1875
100.01880.14060.750.02346120.01170.58590.04690.0469
110.01880.28130.750.0234360.09380.14650.01170.0469
120.07500.11810.3750.0059630.04690.29300.00290.0059
130.03750.11810.3750.37512120.02340.58590.09380.1875
140.07500.11810.3750.093848120.02340.58590.09380.0234
150.01880.14061.50.187596240.04690.29300.02340.0938
160.07500.28131.50.023424240.02340.58590.02340.0938
170.03750.562560.023448240.02340.58590.04690.0469
180.07500.562530.023448120.04690.58590.02340.0469
190.07500.28131.50.011748240.04690.58590.02340.0938
200.07500.562560.011796240.02341.17190.02340.0938
MIC90 b 0.07500.562530.187548240.04691.17190.04690.0938

Isolates 1–5 are Treponema medium/Treponema vincentii‐like BDD spirochaetes with antibiotic test ranges (μg/L) of: penicillin G 0.75–0.0059; amoxicillin 2.25–0.0176; oxytetracycline 12–0.0938; tilmicosin 0.375–0.0029; lincomycin 192–1.5; spectinomycin 48–0.375 (Sigma‐Aldrich; Dorset, UK); tildipirosin 0.75–0.0059 (Zuprevo, MSD Animal Health; Milton Keynes, UK); tulathromycin 9.375–0.0732 (Draxxin, Zoetis UK Limited; London, UK); gamithromycin 0.188–0.0015 (Merial LLC; Duluth, Georgia, USA); and tylosin 0.375–0.0029 (Sigma‐Aldrich).

Isolates 6–15 are Treponema phagedenis‐like CODD spirochaetes and isolates 16–20 are Treponema pedis CODD spirochaetes with test ranges the same as those for Treponema medium/Treponema vincentii‐like BDD spirochaetes.

Cumulative susceptibility results across all treponemes tested are expressed as MIC90, the concentration at which 90% of CODD‐associated treponemes were inhibited.

Minimum inhibitory concentrations (MIC) of 10 antimicrobial agents tested against contagious ovine digital dermatitis associated treponemes Isolates 1–5 are Treponema medium/Treponema vincentii‐like BDD spirochaetes with antibiotic test ranges (μg/L) of: penicillin G 0.75–0.0059; amoxicillin 2.25–0.0176; oxytetracycline 12–0.0938; tilmicosin 0.375–0.0029; lincomycin 192–1.5; spectinomycin 48–0.375 (Sigma‐Aldrich; Dorset, UK); tildipirosin 0.75–0.0059 (Zuprevo, MSD Animal Health; Milton Keynes, UK); tulathromycin 9.375–0.0732 (Draxxin, Zoetis UK Limited; London, UK); gamithromycin 0.188–0.0015 (Merial LLC; Duluth, Georgia, USA); and tylosin 0.375–0.0029 (Sigma‐Aldrich). Isolates 6–15 are Treponema phagedenis‐like CODD spirochaetes and isolates 16–20 are Treponema pedis CODD spirochaetes with test ranges the same as those for Treponema medium/Treponema vincentii‐like BDD spirochaetes. Cumulative susceptibility results across all treponemes tested are expressed as MIC90, the concentration at which 90% of CODD‐associated treponemes were inhibited.

Determination of MICs

The MIC for each antimicrobial was taken as the lowest concentration of antimicrobial that prevented growth in the wells observed at the same time points.6 Cell growth was determined by comparison of the absorbance measurement immediately after inoculation with the absorbance measured at the late exponential/early stationary phase. All of the absorbance measurements were at 540 nm using a Multiskan microtitre plate reader (Thermo Scientific; Hampshire, UK). The MIC values were taken as the median of three repeat experiments, performed on different days.

Determination of MBCs

The MBC for each antimicrobial was determined as previously described.6

Determination of MIC90 and MBC90

The cumulative inhibitory/bactericidal concentration for each antimicrobial tested across all the treponeme isolates was expressed as the concentration at which 90% of CODD‐associated treponemes were inhibited from growing (MIC90) or killed (MBC90).

Statistical analysis

Differences in MICs between the three different treponeme phylogroups were assessed using the Kruskal–Wallis test. The Kruskal–Wallis test and the nonparametric equality‐of‐medians test were used to compare the MICs for penicillin, oxytetracycline, lincomycin and spectinomycin with previous data,6 and for amoxicillin and gamithromycin.7 All statistical analyses were conducted using Stata IC 13 (Stata Corp; College Station, TX, USA) and statistical significance was set at P < 0.05.

Study validation

The MIC microdilution method described in this study was validated by comparing the results produced from four antimicrobials (penicillin, oxytetracycline, lincomycin and erythromycin) incubated with two control microorganisms T. phagedenis biotype Reiter and T. phagedenis‐like T320A against results previously obtained using a macrodilution method8 and also results obtained using a similar microdilution method.6, 7 The data were also compared statistically using linear regression.

Results

Antimicrobial susceptibilities of CODD‐associated treponemes

The individual MIC/MBCs of the antimicrobial agents to each treponeme isolate are summarized in Tables 2 and 3; in this study all isolates showed low MIC/MBCs to all of the antimicrobials tested. Using Table 2, all treponeme groups were most susceptible to gamithromycin and tildipirosin, and least susceptible to lincomycin, spectinomycin and oxytetracycline. The MIC90 for the other five antimicrobials were all relatively low, being <1.0 μg/mL. No bimodal distributions were identified.
Table 3

Minimum bactericidal concentrations (MBC) of 10 antimicrobial agents tested against contagious ovine digital dermatitis associated treponemes

Strain no.a Median MBC (mg/L)
PenicillinAmoxicillinOxytetracyclineTilmicosinLincomycinSpectinomycinTildipirosinTulathromycinGamithromycinTylosin
10.07500.562560.093848120.04690.58590.04690.0938
20.07500.562530.046996240.04690.29300.04690.0938
30.07501.125030.023448240.04691.17190.04690.0938
40.07500.562530.046948240.04690.58590.02340.0938
50.07500.562560.023424240.04691.17190.04690.0938
60.03750.562560.046948120.09380.58590.04690.3750
70.03750.562530.187524240.09380.58590.02340.0938
80.07500.562530.187524120.04691.17190.02340.3750
90.07500.562560.187596240.09380.11720.04690.1875
100.03750.281360.023496120.02340.58590.04690.0469
110.01890.281330.02344860.37500.58590.01170.0469
120.07500.28131.50.01172460.04690.58590.01170.0117
130.03750.11810.750.187524120.02341.17190.09380.1875
140.07500.56250.3750.093848120.02340.58590.09380.0938
150.01880.28130.750.187524120.04690.58590.02340.0938
160.07500.562530.023448240.04690.58590.04690.0938
170.07500.562560.023496240.04690.58590.04690.0938
180.07500.562560.046948120.04691.17190.02340.0938
190.07500.562560.046948240.04691.17190.04690.0938
200.07500.562560.023496240.02341.17190.04690.0938
MBC90 b 0.07500.562560.187596240.09381.17190.04690.1875

1–5, Treponema medium/Treponema vincentii‐like; 6–15, Treponema phagedenis‐like; 16–20, Treponema pedis.

Cumulative susceptibility results across all treponemes tested are expressed as MBC90, the concentration at which 90% of CODD‐associated treponemes were killed.

Minimum bactericidal concentrations (MBC) of 10 antimicrobial agents tested against contagious ovine digital dermatitis associated treponemes 1–5, Treponema medium/Treponema vincentii‐like; 6–15, Treponema phagedenis‐like; 16–20, Treponema pedis. Cumulative susceptibility results across all treponemes tested are expressed as MBC90, the concentration at which 90% of CODD‐associated treponemes were killed.

Variation in MIC across the different treponeme phylogroups

There was no significant difference in MIC values between the three different phylogroups for five of the seven macrolides (P = 0.2), with phylogroup differences for lincomycin and spectinomycin approaching significance (P = 0.05). Whilst there was no significant difference between phylogroups in the case of penicillin MIC (P = 0.1), in the case of amoxicillin and oxytetracycline, T. phagedenis‐like bacteria were more susceptible compared to T. medium/T. vincentii‐like and T. pedis (P = 0.002 and P = 0.001, respectively).

Comparisons with data from previous studies

The MICs for penicillin, oxytetracycline, lincomycin, spectinomycin, amoxicillin and gamithromycin for the 20 isolates investigated here, were not significantly different to those previously reported.6, 7 The comparison described matched the previous results in all cases except for one antimicrobial (oxytetracycline), which was different by one serial dilution when compared with the macrodilution method.8 Linear regression for these comparisons showed strong correlations (R = 0.99 P < 0.004) indicating the efficacy and reproducibility of this microdilution method.

Discussion

Study validation and comparisons with data from previous studies

The methodological validations described reinforce the comparable nature of these current data with previous studies. Comparisons of these current data for penicillin, oxytetracycline, lincomycin and spectinomycin with previous studies do not reveal any statistically significant differences.6, 7 Therefore, these current data make a valuable contribution to the available data on the in vitro antimicrobial susceptibility of these treponemes.

Antimicrobial use in sheep with CODD

All of the isolates in this study were susceptible (in vitro) to all the antimicrobials tested, with gamithromycin, tildipirosin, penicillin, tylosin and tilmicosin demonstrating the lowest MICs and MBCs. This susceptibility, however, may not necessarily be reflected in vivo. To date, there have been very few robust in vivo studies examining effective treatment. In two clinical studies4, 9 systemic amoxicillin together with topical chlortetracycline was found to have a clinical cure rate in clinical cases of CODD of approximately 80%. Anecdotally, systemic tilmicosin was also proposed to be an effective treatment for sheep with CODD10 and systemic oxytetracycline together with a tylosin footbath were considered to be an effective preventative method.3 Currently, no antimicrobial product has a license for CODD in the UK. The antimicrobials studied here were selected to include antimicrobials that already have a license for sheep (penicillin, amoxicillin, oxytetracycline and tilmicosin) together with those that in the authors’ experience are already used (off label) in the sheep industry. Therefore, given this context and these data as a whole, penicillin and tilmicosin would appear to be the most likely candidates for future in vivo studies. This study provides the first detailed examination of the in vitro antimicrobial susceptibilities of all three associated phylogroups of treponemes cultured from CODD lesions to antimicrobials. As such, these data provide important in vitro information on antimicrobials currently used to treat this disease and should help inform researchers planning further in vivo studies when considering which products to include.
  9 in total

1.  Severe foot lesions in sheep.

Authors:  C L Watson
Journal:  Vet Rec       Date:  1999-12-11       Impact factor: 2.695

2.  Effects of parenteral amoxicillin on recovery rates and new infection rates for contagious ovine digital dermatitis in sheep.

Authors:  J S Duncan; D Grove-White; J W H Oultram; C J Phythian; J V Dijk; S D Carter; P J Cripps; H J Williams
Journal:  Vet Rec       Date:  2011-08-31       Impact factor: 2.695

3.  Impact of footrot vaccination and antibiotic therapy on footrot and contagious ovine digital dermatitis.

Authors:  J S Duncan; D Grove-White; E Moks; D Carroll; J W Oultram; C J Phythian; H W Williams
Journal:  Vet Rec       Date:  2012-01-21       Impact factor: 2.695

4.  Inhibition of growth of treponemes by antimicrobial agents.

Authors:  I J Abramson; R M Smibert
Journal:  Br J Vener Dis       Date:  1971-12

5.  High-level association of bovine digital dermatitis Treponema spp. with contagious ovine digital dermatitis lesions and presence of Fusobacterium necrophorum and Dichelobacter nodosus.

Authors:  L E Sullivan; S R Clegg; J W Angell; K Newbrook; R W Blowey; S D Carter; J Bell; J S Duncan; D H Grove-White; R D Murray; N J Evans
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

Review 6.  Treatment strategies for digital dermatitis for the UK.

Authors:  R A Laven; D N Logue
Journal:  Vet J       Date:  2006-01       Impact factor: 2.688

7.  In vitro susceptibility of bovine digital dermatitis associated spirochaetes to antimicrobial agents.

Authors:  Nicholas J Evans; Jennifer M Brown; Ibrahim Demirkan; Richard Birtles; C Anthony Hart; Stuart D Carter
Journal:  Vet Microbiol       Date:  2008-10-30       Impact factor: 3.293

Review 8.  Contagious ovine digital dermatitis: an emerging disease.

Authors:  J S Duncan; J W Angell; S D Carter; N J Evans; L E Sullivan; D H Grove-White
Journal:  Vet J       Date:  2014-06-10       Impact factor: 2.688

9.  Antimicrobial susceptibility testing of bovine digital dermatitis treponemes identifies macrolides for in vivo efficacy testing.

Authors:  N J Evans; J M Brown; C Hartley; R F Smith; S D Carter
Journal:  Vet Microbiol       Date:  2012-06-13       Impact factor: 3.293

  9 in total
  3 in total

1.  Seasonal variation in the gut microbiota of rhesus macaques inhabiting limestone forests of southwest Guangxi, China.

Authors:  Yuhui Li; Ting Chen; Jipeng Liang; Youbang Li; Zhonghao Huang
Journal:  Arch Microbiol       Date:  2020-10-14       Impact factor: 2.552

2.  Whole-flock, metaphylactic tilmicosin failed to eliminate contagious ovine digital dermatitis and footrot in sheep: a cluster randomised trial.

Authors:  J W Angell; D H Grove-White; H J Williams; J S Duncan
Journal:  Vet Rec       Date:  2016-07-22       Impact factor: 2.695

3.  Associations between digital dermatitis lesion grades in dairy cattle and the quantities of four Treponema species.

Authors:  Caroline Beninger; Syed Ali Naqvi; Sohail Naushad; Karin Orsel; Chris Luby; Hooman Derakhshani; Ehsan Khafipour; Jeroen De Buck
Journal:  Vet Res       Date:  2018-10-29       Impact factor: 3.683

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.